Quantcast

Latest emphysema Stories

2010-12-29 14:03:37

A team of Johns Hopkins Children's Center researchers has discovered that a protein involved in cystic fibrosis (CF) also regulates inflammation and cell death in emphysema and may be responsible for other chronic lung diseases. The findings, published online in the December issue of The Journal of Immunology, pave the way toward new treatments to prevent lung damage caused by infections or cigarette smoke in emphysema. The protein, called CFTR (cystic fibrosis transmembrane conductance...

2010-12-09 12:41:00

RESEARCH TRIANGLE PARK, N.C., Dec. 9, 2010 /PRNewswire-FirstCall/ -- Talecris Biotherapeutics, Inc. (Nasdaq: TLCR) announced today the initiation of a clinical trial evaluating the safety and the pharmacokinetic profile of two doses of PROLASTIN®-C (Alpha(1)-Proteinase Inhibitor [Human]) (A1PI), a therapy indicated for chronic augmentation and maintenance in adults with emphysema due to alpha(1)-antitrypsin (AAT) deficiency. AAT deficiency is a rare, genetic disorder in...

2010-11-17 12:00:00

Strategic Plan to Address Chronic Obstructive Pulmonary Disease (COPD) outlines key actions needed to address COPD, the nation's fourth leading killer LOS ANGELES, Nov. 17, 2010 /PRNewswire-USNewswire/ -- The California COPD Coalition, led by the American Lung Association in California, today released its Strategic Plan to Address COPD in California, a comprehensive blueprint for preventing further cases of COPD, improving the quality of life for those with COPD, and enhancing the...

2010-11-17 07:36:00

RESEARCH TRIANGLE PARK, N.C., Nov. 17, 2010 /PRNewswire/ -- Patients with Chronic Obstructive Pulmonary Disease, or COPD, revealed that they perceive their disease as both a burden they must deal with and as a loss they have experienced,(1) according to recent in-home research conducted by GlaxoSmithKline. Patients participating in the research characterized their sense of loss as a combination of factors including loss of energy, loss of control, loss of independence and loss of their...

2010-11-16 07:04:00

IRVINE, Calif., Nov. 16, 2010 /PRNewswire/ -- Uptake Medical Corp., the leading developer of medical technologies for interventional emphysema therapy, announced today that J.C. MacRae has joined the company as its vice president and chief financial officer. MacRae comes to Uptake Medical with over 25 years experience in the medical specialty device and biopharmaceutical product industries. He most recently was a member of the senior management team at CoreValve, Inc., a catheter-based...

2010-11-15 04:00:00

RESEARCH TRIANGLE PARK, N.C., Nov. 15, 2010 /PRNewswire-FirstCall/ -- Talecris Biotherapeutics (Nasdaq: TLCR) announced today the publication of combined data from two studies demonstrating that augmentation therapy with Alpha(1)-Proteinase Inhibitor (Human) (A1PI) significantly reduces lung tissue loss in patients with emphysema related to Alpha(1)-antitrypsin (AAT) deficiency. Results of the studies, published as an integrated analysis of the raw data from two similar pilot trials, were...

2010-11-09 12:00:00

LANSING, Mich., Nov. 9, 2010 /PRNewswire/ -- Bringing awareness to the need for early detection of a genetic disorder that can cause permanent and even fatal organ damage is the main theme of Alpha-1 Antitrypsin Deficiency Month in Michigan. The condition, known as Alpha-1, affects the lungs and liver in children and adults. Today representatives of the Alpha-1 Association, Michigan doctors who treat and advocate for patients with the disease and CSL Behring joined Governor Jennifer M....

2010-11-01 07:06:00

IRVINE, Calif., Nov. 1, 2010 /PRNewswire/ -- Uptake Medical Corp., a developer of medical technologies for the nonsurgical treatment of lung diseases including emphysema, announced today that Dr. Steven Kesten will join the company as its vice president and chief medical officer effective November 3, 2010. Dr. Kesten joins Uptake Medical with over 20 years experience in pulmonary medicine including academic research and clinical leadership in the pulmonary industry. He served at...

2010-10-28 15:16:39

A team of researchers from Boston University's Center for Regenerative Medicine and the Pulmonary Center have generated 100 new lines of human induced pluripotent stem cells (iPSC) from individuals with lung diseases, including cystic fibrosis and emphysema. The new stem cell lines could possibly lead to new treatments for these debilitating diseases. The findings, which appear in the current issue of Stem Cells, demonstrate the first time lung disease-specific iPSC have been created in a...

2010-10-21 12:49:00

RESEARCH TRIANGLE PARK, N.C., Oct. 21 /PRNewswire/ -- Talecris Biotherapeutics (Nasdaq: TLCR) today announced the publication of results from a study showing that PROLASTIN®-C (Alpha1-Proteinase Inhibitor [Human]) (A1PI) is as effective as PROLASTIN® (Alpha1-Proteinase Inhibitor [Human]) in raising levels of alpha-1 protein in patients with alpha1-antitrypsin (AAT) deficiency. Results of the pharmacokinetic study are published in BMC Clinical...


Latest emphysema Reference Libraries

Lung
2013-01-01 15:53:59

The lung is a vital organ that is a part of the respiratory system. Generally a person has two lungs; however, the body can function with only one. The lung’s main function is to move oxygen and carbon dioxide into and out of the bloodstream through gas exchange. The lungs are located lateral to the heart in the thoracic cavity. Each lung has a tip called the apex, which is superior in the body. The bases of the lungs rest on the diaphragm. They appear to be spongy due to their bundles of...

More Articles (1 articles) »
Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.